Literature DB >> 10810624

Adenovirus-mediated herpes simplex thymidine kinase gene therapy for brain tumors.

A M Sandmair1, M Vapalahti, S Ylä-Herttuala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10810624     DOI： 10.1007/0-306-46817-4_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

1.  Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.

Authors:  Winan J Van Houdt; Hongju Wu; Joel N Glasgow; Martine L Lamfers; Clemens M Dirven; G Yancey Gillespie; David T Curiel; Yosef S Haviv
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

2.  Gene- and viral-based therapies for brain tumors.

Authors:  Kaveh Asadi-Moghaddam; E Antonio Chiocca
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses.

Authors:  Padma Sampath; Steve H Thorne
Journal:  Oncolytic Virother       Date:  2013-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.